Heier Jeffrey S.; Khanani Arshad M.; Ruiz Carlos Quezada; Basu Karen; Ferrone Philip J.; Brittain Christopher; Figueroa Marta S.; Lin Hugh; Holz Frank G.; Patel Vaibhavi; Lai Timothy Y. Y.; Silverman David; Tóth-Molnár Edit; Zatorska Barbara; Kollaborációs szervezet: TENAYA and LUCERNE Investigators (kollab. közrem.):
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
LANCET, 399 (10326).
pp. 729-740.
ISSN 0140-6736
(2022)